Summary:
Click image to enlarge
A trial called rimegepant BHV3000 to assess an investigational drug that could offer a potential new approach to treatment. This clinical research study will ask if that investigational drug is a safe and effective treatment for people who:
Qualified Participants Must:
• Have been diagnosed with migraines at least 1 year ago and before 50 years of age
•
Have had 2-to-8 moderate to severe migraines (with or without aura) each month for the last 3 months
•
Be 18 years of age or older
Qualified Participants May Receive:
- Investigational drug and study assessments at no cost
- Compensation for travel